Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
Shield Therapeutics
Shield Therapeutics
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
No data
Company Revenue
No data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Accrufer
Ferric maltol
2019-07-25
2031-2035
Iron-deficiency anemia
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Ferric maltol
deficiency diseases
,
crohn disease
,
hypertension
,
pulmonary hypertension
,
chronic renal insufficiency
,
kidney diseases
,
renal insufficiency
,
ulcerative colitis
,
colitis
,
ulcer
,
colonic neoplasms
,
iron-deficiency anemia
,
iron deficiencies
,
anemia
,
inflammatory bowel diseases
,
intestinal diseases
,
heart failure
,
infertility
,
aneuploidy
,
chalazion
,
non-small-cell lung carcinoma
,
lung neoplasms
,
adenocarcinoma of lung
Aspartame
prostatic hyperplasia
,
healthy volunteers/patients
,
respiratory tract diseases
,
respiration disorders
,
hyperhidrosis
,
kidney diseases
,
obesity
,
weight loss
,
burns
,
bronchiectasis
,
respiratory tract infections
,
skin diseases
,
premature obstetric labor
,
heart failure
,
pulmonary edema
,
amyloidosis
,
bacterial infections
,
liver diseases
,
hepatic insufficiency
,
sepsis
,
neoplasms
,
multiple myeloma
,
plasma cell neoplasms
,
common cold
,
breast neoplasms
,
rhinitis
,
tuberculosis
,
atherosclerosis
,
obstructive lung diseases
,
virus diseases
,
pancreatic neoplasms
,
lymphoma
,
follicular lymphoma
,
allergic rhinitis
,
pulmonary tuberculosis
,
coronary disease
,
coronary artery disease
,
myocardial ischemia
,
heart diseases
,
carcinoma
,
hepatocellular carcinoma
,
liver neoplasms
,
precursor cell lymphoblastic leukemia-lymphoma
,
precursor t-cell lymphoblastic leukemia-lymphoma
,
sjogren's syndrome
,
xerostomia
,
ulcer
,
buruli ulcer
,
hiv infections
,
malaria
,
systemic lupus erythematosus
,
infections
,
acquired immunodeficiency syndrome
,
vivax malaria
,
type 2 diabetes mellitus
,
human influenza
,
communicable diseases
,
hemolysis
,
bone fractures
,
parkinson disease
,
pemphigus
,
migraine disorders
,
depression
,
major depressive disorder
,
depressive disorder
,
churg-strauss syndrome
,
granulomatosis with polyangiitis
,
systemic vasculitis
,
eosinophilic granuloma
,
neisseria meningitidis
,
haemophilus influenzae type b
,
restless legs syndrome
,
psychomotor agitation
,
syndrome
,
covid-19
,
arthralgia
,
ovarian neoplasms
,
ovarian epithelial carcinoma
,
anthrax
,
asthma
,
chronic obstructive pulmonary disease
,
lung diseases
,
diabetes mellitus
,
hepatitis
,
hepatitis a
,
nausea
,
pulmonary eosinophilia
,
prostatic neoplasms
,
hyperplasia
,
growth and development
,
neuralgia
,
herpes zoster
,
postherpetic neuralgia
,
herpes simplex
Nepidermin
epilepsy
,
seizures
,
partial epilepsies
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use